HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Masahiro Tohkin Selected Research
Masahiro Tohkin Research Topics
Disease
6
Neoplasms (Cancer)
11/2021 - 01/2009
6
Stevens-Johnson Syndrome (Lyell's Syndrome)
01/2021 - 11/2008
4
Multiple Myeloma
12/2021 - 10/2019
2
Cicatrix (Scar)
01/2021 - 01/2021
2
Type 2 Diabetes Mellitus (MODY)
01/2020 - 05/2006
2
Weight Gain
01/2019 - 05/2006
1
Pneumonia (Pneumonitis)
12/2021
1
Acute Kidney Injury (Acute Renal Failure)
11/2021
1
Fibrosarcoma
11/2021
1
Melanoma (Melanoma, Malignant)
11/2021
1
Chronic Renal Insufficiency
01/2021
1
Dysuria
01/2021
1
Schizophrenia (Dementia Praecox)
01/2021
1
Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2021
1
Hypersensitivity (Allergy)
01/2021
1
Tumor Lysis Syndrome
01/2020
1
Peripheral Nervous System Diseases (PNS Diseases)
10/2019
1
Hepatitis B
01/2018
1
Infections
01/2018
1
Skin Diseases (Skin Disease)
01/2018
1
Cardiovascular Diseases (Cardiovascular Disease)
01/2017
1
Myocardial Ischemia (Ischemic Heart Diseases)
01/2017
1
Heart Failure
01/2017
1
Lactic Acidosis
06/2015
1
Cholestasis
05/2015
1
Alzheimer Disease (Alzheimer's Disease)
01/2015
1
Hypertrophy
01/2015
1
Psoriasis (Pustulosis Palmaris et Plantaris)
01/2012
1
Stomach Neoplasms (Stomach Cancer)
01/2012
1
Breast Neoplasms (Breast Cancer)
01/2012
1
Hand-Foot Syndrome
01/2012
1
Hypoxia (Hypoxemia)
01/2011
1
Drug-Related Side Effects and Adverse Reactions
01/2010
1
Muscular Diseases (Myopathy)
01/2010
1
Body Weight (Weight, Body)
05/2008
Drug/Important Bio-Agent (IBA)
5
Biomarkers (Surrogate Marker)
IBA
12/2021 - 01/2010
5
Pharmaceutical Preparations
IBA
11/2021 - 01/2015
4
Bortezomib (Velcade)
FDA Link
12/2021 - 01/2018
4
HLA-B Antigens (HLA-B)
IBA
01/2021 - 11/2008
3
Allopurinol (Remid)
FDA Link
Generic
01/2021 - 11/2008
2
Phenytoin (Dilantin)
FDA Link
Generic
01/2021 - 11/2013
2
Carbamazepine (Tegretol)
FDA Link
Generic
01/2021 - 12/2010
2
Lenalidomide (CC 5013)
FDA Link
04/2020 - 01/2020
2
Glucose (Dextrose)
FDA Link
Generic
01/2020 - 01/2018
2
Sodium
IBA
01/2020 - 01/2018
2
Symporters
IBA
01/2020 - 01/2018
2
Xenobiotics
IBA
01/2015 - 01/2011
1
HLA-DRB1 Chains (HLA DRB1)
IBA
12/2021
1
Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
IBA
11/2021
1
Phosphotransferases (Kinase)
IBA
11/2021
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
11/2021
1
Mitogens
IBA
11/2021
1
insulin receptor-related receptor (IRR)
IBA
01/2021
1
Tadalafil (Cialis)
FDA Link
01/2021
1
asenapine
FDA Link
01/2021
1
Dexamethasone (Maxidex)
FDA Link
Generic
04/2020
1
Thalidomide (Thalomid)
FDA Link
01/2020
1
Proteasome Inhibitors
IBA
10/2019
1
Diethylhexyl Phthalate (DEHP)
IBA
01/2019
1
p38 Mitogen-Activated Protein Kinases
IBA
02/2018
1
Drug Combinations
IBA
01/2018
1
Everolimus
FDA Link
01/2018
1
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2018
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2018
1
fludarabine
IBA
01/2018
1
Azacitidine (5 Azacytidine)
FDA Link
01/2018
1
Antineoplastic Agents (Antineoplastics)
IBA
01/2018
1
Sodium-Glucose Transporter 2 Inhibitors
IBA
01/2018
1
Docetaxel (Taxotere)
FDA Link
01/2018
1
Paclitaxel (Taxol)
FDA Link
Generic
01/2018
1
Rituximab (Mabthera)
FDA Link
01/2018
1
Trastuzumab (Herceptin)
FDA Link
01/2018
1
Imatinib Mesylate (Gleevec)
FDA Link
01/2018
1
taxane
IBA
01/2018
1
Antihypertensive Agents (Antihypertensives)
IBA
01/2017
1
Diuretics
IBA
01/2017
1
Metformin (Glucophage)
FDA Link
Generic
06/2015
1
Lactic Acid (Lactate)
FDA Link
Generic
06/2015
1
Phenobarbital (Luminal)
FDA Link
11/2013
1
Anticonvulsants (Antiepileptic Drugs)
IBA
11/2013
1
Zonisamide (Zonegran)
FDA Link
Generic
11/2013
1
Carcinoembryonic Antigen
IBA
01/2012
1
Prodrugs
IBA
01/2012
1
Antigens
IBA
01/2012
1
Tumor Biomarkers (Tumor Markers)
IBA
01/2012
1
Fluorouracil (Carac)
FDA Link
Generic
01/2012
1
Carbohydrates
IBA
01/2012
1
Capecitabine (Xeloda)
FDA Link
01/2012
1
Elements
IBA
01/2011
1
Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)
IBA
01/2011
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
01/2010
1
Cytarabine (Cytosar-U)
FDA Link
Generic
01/2009
1
Gemcitabine
FDA Link
01/2009
1
Cytidine Deaminase
IBA
01/2009
1
Polychlorinated Dibenzodioxins (TCDD)
IBA
05/2008
1
glimepiride (Amarel)
FDA Link
Generic
05/2006
Therapy/Procedure
7
Therapeutics
11/2021 - 03/2005
4
Drug Therapy (Chemotherapy)
11/2021 - 01/2010
1
Antineoplastic Combined Chemotherapy Protocols
01/2018
1
Time-to-Treatment
01/2012